title: Dual-Use Review and the IRB.
abstract: Given the growing threat of the misuse of biomedical research by terrorists or others, institutional review boards (IRBs) are likely to encounter research protocols that raise dual-use issues. While IRBs should be informed about these issues and should be prepared to address them, they should not be burdened with the responsibility of conducting their own dual-use review. A dual-use committee (DUC), institutional biosafety committee (IBC), or other committee should handle this task and convey its findings and recommendations to institutional officials.
authors.affiliation: Bioethicist and IRB Chair at the National Institute of Environmental Health Science, National Institutes of Health.
authors.forename: David B
authors.initials: DB
authors.lastname: Resnik